Thermo Fisher Scientific Inc. (TMO): Seth H Hoogasian , Sr. VP, Gen. Counsel & Sec. of Thermo Fisher Scientific Inc. sold 10,000 shares on Apr 5, 2016. The Insider selling transaction was disclosed on Apr 7, 2016 to the Securities and Exchange Commission. The shares were sold at $142.05 per share for a total value of $1,418,580.00.
Company has been under the radar of several Street Analysts.Thermo Fisher Scientific is Reiterated by Mizuho to Buy and the brokerage firm has raised the Price Target to $ 160 from a previous price target of $150 .The Rating was issued on Apr 4, 2016.Thermo Fisher Scientific is Reiterated by Topeka Capital Markets to Buy and the brokerage firm has raised the Price Target to $ 155 from a previous price target of $145 .The Rating was issued on Mar 2, 2016.Thermo Fisher Scientific is Reiterated by Stifel to Buy and the brokerage firm has raised the Price Target to $ 158 from a previous price target of $150 .The Rating was issued on Jan 11, 2016.
Currently the company Insiders own 0.56% of Thermo Fisher Scientific shares according to the proxy statements.In the past twelve weeks, the net percent change held by company insiders has changed by -8.36%.Institutional Investors own 88.75% of Thermo Fisher Scientific shares.During last six month period, the net percent change held by insiders has seen a change of -7.45%.
Thermo Fisher Scientific: On Monday, Apr 4, 2016 heightened volatility was witnessed in Thermo Fisher Scientific which led to swings in the share price. The shares opened for trading at $142.18 and hit $144.93 on the upside , eventually ending the session at $144.05, with a gain of 0.97% or 1.38 points. The heightened volatility saw the trading volume jump to 18,51,979 shares. The 52-week high of the share price is $144.93 and the company has a market cap of $57,082 M . The 52-week low of the share price is at $117.1.
Thermo Fisher Scientific Inc. is a provider of analytical instruments equipment reagents and consumables software and services for research manufacturing analysis discovery and diagnostics. The company operates through four segments: Life Sciences Solutions provides reagents instruments and consumables used in biological and medical research discovery and production of new drugs and vaccines as well as diagnosis of disease; Analytical Instruments provides instruments consumables software and services that are used in the laboratory; Specialty Diagnostics offers diagnostic test kits reagents culture media instruments and associated products and Laboratory Products and Services offers self-manufactured and sourced products for the laboratory.